Evaluation of patients with acute chest pain of uncertain origin by means of serial measurement of high-sensitivity C-reactive protein;Evaluación de los pacientes con dolor torácico agudo de origen incierto mediante la determinación seriada de los valores de proteína C reactiva de alta sensibilidad

Revista Espanola de Cardiologia

Volumn 60, Issue 8, 2007, Pages 817-824

  Lozano, Teresa ^a   Ena, Javier ^a   Almenar, Vicenta ^a   Graells, Marisa ^b   Molina, Juan ^a   Antorrena, Isabel ^a   De La Guía, Fernando ^a  

^a HOSPITAL MARINA BAIXA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

C reactive protein; Chest pain; Coronary disease; Likelihood ratio; Sensitivity; Specificity

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART MUSCLE CELL; HEART MUSCLE INJURY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; THORAX PAIN; ACUTE DISEASE; BLOOD; DECISION TREE; HEART INFARCTION; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYNDROME; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ANGINA, UNSTABLE; C-REACTIVE PROTEIN; CHEST PAIN; DECISION TREES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SYNDROME;

EID: 34548035456     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13108995     Document Type: Article

References (17)

1. Farkouh ME, Smars PA, Reder GS, Zinsmeister AR, Evans RW, Kopecky SL, et al. A Clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in Emergency Room (CHEER) Investigators. N Eng J Med. 1998; 339:1882-8.
2. Erhardt L, Herlitz J, Bossaert L, Halinen M, Keltai M, Koster R, et al. Task force on the management of chest pain. Eur Heart J. 2002;23:1153-76.
3. Escolar E, Weigold G, Fuisz A, Weissman NJ. New imaging techniques for diagnosing coronary artery disease. CMAJ. 2006; 174:487-95.
4. Debashis R, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, et al. Ischemia Modified Albumin for the assesment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol. 2004;97:297-301.
5. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ. 2005;172:1685-90.
6. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Eng J Med. 2003;349:1595-604.
7. De Winter RJ, Fischer J, Bholasingh R, Van Straalen JP, De Jong T, Tijssen JG, et al. C-reactive protein and cardiac troponin T in risk stratification: differences in optimal timing of test early after the onset of chest pain. Clin Chem. 2000;46:1597-603.
8. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy. The STARD iniciative. Clin Chem. 2003;49:1-6.
9. Prasad K. C-reactive protein lowering agents. Cardiovasc Drug Rev. 2006;24:33-50.
10. Sánchez PL, Rodríguez MV, Villacorta E, Albarrán C, Cruz I, Moreiras JM, et al. Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo. Rev Esp Cardiol. 2006;59:441-7.
11. De Winter RJ, Fischer JC, De Jongh T, Van Straalen JP, Bholasingh R, Sanders GT. Different time frames for the occurrence of elevated levels of cardiac troponin T and C-reactive protein in patients with acute myocardial infarction. Clin Chem Lab Med. 2000;38:1151-3.
12. Bodí V, Sanchís J, Llácer A, Fácila L, Núñez J, Pellicer M, et al. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J. 2005;149:268-74.
13. Heeschen C, Dimmeler S, Hamm C, Van den Brand MJ, Boersma E, Zeiher A, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:1104-11.
14. Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J. 2005; 26:457-63.
15. Yamashita H, Shimada K, Seki E, Mokuno H, Daida H. Concentrations of interleukins, interferon, and C-Reactive protein in stable and unstable angina pectoris. Am J Cardiol. 2003;91:133-6.
16. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, et al, for the AtheroGene investigators. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J. 2005;26:241-9.
17. Menown IB, Mathew TP, Gracey HM, Nesbitt GS, Murray P, Young IS, et al. Prediction of recurrent events by D-Dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT) Study. Am Heart J. 2003;145:986-92.